Julie Teruya‐Feldstein

32.3k total citations · 7 hit papers
216 papers, 22.2k citations indexed

About

Julie Teruya‐Feldstein is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Julie Teruya‐Feldstein has authored 216 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 89 papers in Pathology and Forensic Medicine and 88 papers in Molecular Biology. Recurrent topics in Julie Teruya‐Feldstein's work include Lymphoma Diagnosis and Treatment (84 papers), Viral-associated cancers and disorders (46 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Julie Teruya‐Feldstein is often cited by papers focused on Lymphoma Diagnosis and Treatment (84 papers), Viral-associated cancers and disorders (46 papers) and Chronic Lymphocytic Leukemia Research (32 papers). Julie Teruya‐Feldstein collaborates with scholars based in United States, Italy and Japan. Julie Teruya‐Feldstein's co-authors include Li Ma, Robert A. Weinberg, Pier Paolo Pandolfi, Carlos Cordon‐Cardo, Giovanna Tosato, Elaine S. Jaffe, Ainara Egia, Arkaitz Carracedo, Scott W. Lowe and Leonardo Salmena and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Julie Teruya‐Feldstein

216 papers receiving 21.8k citations

Hit Papers

Tumour invasion and metastasis initiated by microRNA-10b ... 2007 2026 2013 2019 2007 2008 2010 2011 2010 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
    2007 2.1k citations Li Ma, Julie Teruya‐Feldstein et al. profile →
  2. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
    2008 1.1k citations Li Ma, Julie Teruya‐Feldstein et al. profile →
  3. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
    2010 1.1k citations Li Ma, Jennifer J. Young et al. profile →
  4. SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
    2011 659 citations Julie Teruya‐Feldstein, Pier Paolo Pandolfi et al. profile →
  5. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
    2010 608 citations Li Ma, Ferenc Reinhardt et al. profile →
  6. Ubiquitination Regulates PTEN Nuclear Import and Tumor Suppression
    2007 593 citations Julie Teruya‐Feldstein, Pier Paolo Pandolfi et al. profile →
  7. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
    2014 398 citations Aruna Kode, Ioanna Mosialou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Teruya‐Feldstein United States 77 13.1k 7.6k 5.5k 4.2k 3.2k 216 22.2k
Kevin C. Gatter United Kingdom 88 12.7k 1.0× 8.2k 1.1× 8.4k 1.5× 4.7k 1.1× 3.6k 1.1× 311 26.8k
Andrew L. Kung United States 81 16.6k 1.3× 6.6k 0.9× 4.6k 0.8× 1.2k 0.3× 2.9k 0.9× 285 24.2k
Joseph R. Testa United States 83 14.1k 1.1× 5.4k 0.7× 3.9k 0.7× 2.4k 0.6× 1.9k 0.6× 347 24.5k
Jonathan Said United States 73 8.5k 0.6× 8.2k 1.1× 3.5k 0.6× 4.5k 1.1× 2.4k 0.8× 370 20.5k
Giorgio Inghirami United States 69 6.1k 0.5× 8.0k 1.1× 2.1k 0.4× 5.9k 1.4× 4.3k 1.4× 268 16.8k
Hiroyuki Mano Japan 66 9.4k 0.7× 8.4k 1.1× 4.6k 0.8× 2.1k 0.5× 2.3k 0.7× 262 19.5k
Ruggero De Maria Italy 72 13.1k 1.0× 9.1k 1.2× 6.1k 1.1× 971 0.2× 4.0k 1.2× 257 22.8k
Adolfo A. Ferrando United States 65 15.8k 1.2× 3.8k 0.5× 8.6k 1.6× 1.7k 0.4× 2.9k 0.9× 164 23.7k
Giorgio Cattoretti Italy 54 6.6k 0.5× 4.2k 0.5× 1.9k 0.3× 3.6k 0.9× 4.9k 1.5× 183 16.3k
Antonino Neri Italy 64 7.9k 0.6× 4.7k 0.6× 3.5k 0.6× 3.7k 0.9× 2.6k 0.8× 410 14.5k

Countries citing papers authored by Julie Teruya‐Feldstein

Since Specialization
Citations

This map shows the geographic impact of Julie Teruya‐Feldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Teruya‐Feldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Teruya‐Feldstein more than expected).

Fields of papers citing papers by Julie Teruya‐Feldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Teruya‐Feldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Teruya‐Feldstein. The network helps show where Julie Teruya‐Feldstein may publish in the future.

Co-authorship network of co-authors of Julie Teruya‐Feldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Teruya‐Feldstein. A scholar is included among the top collaborators of Julie Teruya‐Feldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Teruya‐Feldstein. Julie Teruya‐Feldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Alexandra N., Matthew J. Maurer, Julie Teruya‐Feldstein, et al.. (2024). Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood Advances. 8(9). 2172–2181. 2 indexed citations
2.
Fangazio, Marco, Erik Ladewig, Laura Garcia‐Ibanez, et al.. (2021). Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences. 118(22). 53 indexed citations
3.
Oekelen, Oliver Van, Adolfo Aleman, Bhaskar Upadhyaya, et al.. (2021). Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nature Medicine. 27(12). 2099–2103. 151 indexed citations
4.
Wheeler, Emily C., Daniel Mayer, Andriana G. Kotini, et al.. (2021). Integrative RNA-omics Discovers GNAS Alternative Splicing as a Phenotypic Driver of Splicing Factor–Mutant Neoplasms. Cancer Discovery. 12(3). 836–855. 32 indexed citations
5.
Bhardwaj, Swati, Shafinaz Hussein, Siraj M. El Jamal, et al.. (2021). Digital AI in Hematology - Integration of the Scopio Labs x100 Scanner with Newly Implemented AI Capabilities into Routine Clinical Workflow. Blood. 138(Supplement 1). 4932–4932. 2 indexed citations
6.
Teruya‐Feldstein, Julie, et al.. (2020). Hypersegmented granulocytes and COVID-19 infection. Blood. 135(24). 2196–2196. 8 indexed citations
7.
Mouhieddine, Tarek H., Yasir Ahmad, Bart Barlogie, et al.. (2020). Increased Muscle CXCR4 Expression in the Setting of Rare Muscle-invasive Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 20(6). e341–e344. 3 indexed citations
8.
Ito, Kyoko, Joun Lee, Stephanie Chrysanthou, et al.. (2019). Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis. Cell Reports. 28(10). 2480–2490.e4. 79 indexed citations
9.
Kode, Aruna, Ioanna Mosialou, Chozhavendan Rathinam, et al.. (2015). FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia. 30(1). 1–13. 73 indexed citations
10.
Bisikirska, Brygida, Mukesh Bansal, Yao Shen, et al.. (2015). Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression. Cancer Research. 76(3). 664–674. 37 indexed citations
11.
Konstantinidou, Georgia, Giorgio Ramadori, Francesca Torti, et al.. (2013). RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas. Cancer Discovery. 3(4). 444–457. 91 indexed citations
12.
Rabellino, Andrea, Brandon Carter, Georgia Konstantinidou, et al.. (2012). The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA. Cancer Research. 72(9). 2275–2284. 94 indexed citations
13.
Schatz, Jonathan H., Elisa Oricchio, Andrew L. Wolfe, et al.. (2011). Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. The Journal of Experimental Medicine. 208(9). 1799–1807. 89 indexed citations
14.
Moskowitz, Craig H., Heiko Schöder, Julie Teruya‐Feldstein, et al.. (2010). Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 28(11). 1896–1903. 225 indexed citations
15.
Reinhardt, Ferenc, Elizabeth Pan, Jürgen Soutschek, et al.. (2010). Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. PMC. 33 indexed citations
16.
Ma, Li, Jennifer J. Young, Harsha Prabhala, et al.. (2010). miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. PMC. 1 indexed citations
17.
Kreisl, Teri, Andrew B. Lassman, Paul S. Mischel, et al.. (2008). A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). Journal of Neuro-Oncology. 92(1). 99–105. 132 indexed citations
18.
Maeda, Takahiro, Taha Merghoub, Robin M. Hobbs, et al.. (2007). Regulation of B Versus T Lymphoid Lineage Fate Decision by the Proto-Oncogene LRF. Science. 316(5826). 860–866. 174 indexed citations
19.
Teruya‐Feldstein, Julie, Elizabeth Y. Chiao, D Filippa, et al.. (2004). CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Annals of Oncology. 15(11). 1673–1679. 157 indexed citations
20.
Teruya‐Feldstein, Julie, et al.. (2002). Analysis of Mismatch Repair Defects in the Familial Occurrence of Lymphoma and Colorectal Cancer. Leukemia & lymphoma. 43(8). 1619–1626. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin C. Gatter Breakdown of academic impact, for papers by Andrew L. Kung Breakdown of academic impact, for papers by Joseph R. Testa Breakdown of academic impact, for papers by Jonathan Said Breakdown of academic impact, for papers by Giorgio Inghirami Breakdown of academic impact, for papers by Hiroyuki Mano Breakdown of academic impact, for papers by Ruggero De Maria Breakdown of academic impact, for papers by Adolfo A. Ferrando Breakdown of academic impact, for papers by Giorgio Cattoretti Breakdown of academic impact, for papers by Antonino Neri
Rankless by CCL
2026